These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12854069)

  • 1. [Real and assumed potential savings in antihypertensive treatment. Right out of the magician's hat].
    Anlauf M; Hense HW
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1557-9. PubMed ID: 12854069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacotherapy of hypertension. How much can safely be saved?].
    Anlauf M
    MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
    [No Abstract]   [Full Text] [Related]  

  • 3. [Health care too costly? Saving more than 10 million euros in 2 months!].
    Rappert B
    MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hypertension. Cost conscious prevention of complications].
    Kolloch RE
    MMW Fortschr Med; 2003 Nov; 145(47):64. PubMed ID: 14725042
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comment on IOWiG report plan. A medical decision may not be replaced].
    Vorstand der Deutschen Hochdruckliga E.V
    MMW Fortschr Med; 2006 May; 148(19):42. PubMed ID: 16736705
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertension therapy--never without diuretics?].
    Anlauf M
    MMW Fortschr Med; 2007 Nov; 149(46):31-3. PubMed ID: 18069189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Innovation or pseudo-innovation: that is the question].
    Unger T
    Med Klin (Munich); 2006 Mar; 101(3):257-62. PubMed ID: 16648986
    [No Abstract]   [Full Text] [Related]  

  • 8. The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis.
    Fretheim A; Aaserud M; Oxman AD
    BMC Health Serv Res; 2003 Sep; 3(1):18. PubMed ID: 12959644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 10. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
    Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 13. [German Hypertension League update. What does the ALLHAT Study really mean?].
    MMW Fortschr Med; 2003 Jun; 145(23):45-6. PubMed ID: 12854226
    [No Abstract]   [Full Text] [Related]  

  • 14. Thiazides first-line treatment for hypertension.
    McCormack J; Rangno R; Wright JM
    Can Fam Physician; 2003 Jul; 49():879. PubMed ID: 12901483
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective.
    Szucs TD; Waeber B; Tomonaga Y
    J Hum Hypertens; 2010 Feb; 24(2):117-23. PubMed ID: 19536166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.
    Amira CO; Okubadejo NU
    J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
    Caro JJ; Lee K
    Curr Hypertens Rep; 2002 Dec; 4(6):418. PubMed ID: 12419167
    [No Abstract]   [Full Text] [Related]  

  • 18. [New treatment strategies for the management of hypertension].
    Reinhardt A; Linsel-Nitschke P; Schunkert H
    MMW Fortschr Med; 2009 Nov; 151(46):33-6. PubMed ID: 20043391
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons from ALLHAT. Are low budget diuretics first line therapy in hypertension?
    Unger T
    Z Kardiol; 2004 May; 93(5):349-56. PubMed ID: 15160270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension.
    Xu KT; Moloney M; Phillips S
    Am J Manag Care; 2003 Aug; 9(8):529-36. PubMed ID: 12921230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.